ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $186,532 | -81.9% | 2,090 | -76.1% | 0.03% | -77.8% |
| Q1 2022 | $1,028,000 | -9.0% | 8,763 | +4.3% | 0.14% | -19.6% |
| Q4 2021 | $1,130,000 | -15.6% | 8,400 | 0.0% | 0.17% | +78.7% |
| Q3 2021 | $1,339,000 | -66.6% | 8,400 | -72.4% | 0.09% | -71.0% |
| Q2 2021 | $4,003,000 | -72.5% | 30,425 | -73.0% | 0.32% | -33.7% |
| Q1 2021 | $14,535,000 | -36.8% | 112,790 | -18.1% | 0.49% | -51.7% |
| Q4 2020 | $22,982,000 | +2.7% | 137,790 | -5.0% | 1.01% | -37.4% |
| Q3 2020 | $22,376,000 | +4.3% | 145,000 | 0.0% | 1.62% | -5.2% |
| Q2 2020 | $21,446,000 | +470.2% | 145,000 | +107.1% | 1.71% | +503.2% |
| Q1 2020 | $3,761,000 | -61.0% | 70,000 | +0.9% | 0.28% | -81.9% |
| Q4 2019 | $9,655,000 | – | 69,400 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |